Online since 07/02/2024
Innovations & Thérapeutiques en Oncologie
To bring knowledge about the largest number of innovations in oncology, trying as accurately as possible to define their benefits, but also their restrictions and limitations.
To echo the everyday impact of both these innovations and also any new methods in clinical practice, new ways of using them and new areas of interest from specific clinical situations.
With its eyes set resolutely on the future, the six annual editions of this Journal will quickly find their home with all French speaking oncologists.
The Innovations & Thérapeutiques en Oncologie review has an editing committee comprised of successful professionals who are expert in their respective sectors. It can therefore offer you excellent content which will contribute to the development of the future of oncology.
Volume 10, issue 1, January-February 2024
Sélection et décryptage/Comments and Analysis
Les Prix Unicancer de l’innovation/Unicancer Innovation PrizesSee full Table of contents >
Here you will find all JLE policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.
- Editorial policy
- Peer review policy
- Commercial policy
- Ethical rules - Links of interest, human and animal rights, informed patient consent
- Corrections, retractions and expressions of reservations
- Copyright, Open Access and data sharing
Ahead of print
By Lonni Besançon
By Mathieu Molimard
By Comité d’organisation de l’Onco Startup Summit